Based on experimental data collected in vivo and vitro studies, this study reveals that resveratrol treatment protected osteoblasts in osteoporosis rats by activating the PI3K/Akt/mTOR signaling pathway through enhancing mitophagy via up-regulating the expression of SIRT1. Here, AKT1 is linked to osteoporosis.